Eli Lilly and Company (LLY)

Index:

S&P 100

$ 750.26
   
  • Change Today:
    $2.25
  • 52 Week High: $960.02
  • 52 Week Low: $570.21
  • Currency: US Dollars
  • Shares Issued: 949.78m
  • Volume: 1,668,494
  • Market Cap: $712,583m
  • RiskGrade: 179
  • Beta: 0.93

Latest ShareCast News

Eli Lilly's quarterly numbers disappoint, shares tumble

By Abigail Townsend

Date: Wednesday 30 Oct 2024

(Sharecast News) - Shares in Eli Lilly & Co fell sharply on Wednesday, after the US drugs firm missed quarterly forecasts and cut its full-year outlook.

Eli Lilly hikes guidance as obesity drug sales soar

By Josh White

Date: Thursday 08 Aug 2024

(Sharecast News) - Eli Lilly significantly raised its full-year revenue forecast by $3bn on Thursday, after reporting a strong second quarter driven by the robust performance of its blockbuster weight loss and diabetes drugs Zepbound and Mounjaro.

Eli Lilly hikes guidance as obesity drug sales soar

By Josh White

Date: Thursday 08 Aug 2024

(Sharecast News) - Eli Lilly significantly raised its full-year revenue forecast by $3bn on Thursday, after reporting a strong second quarter driven by the robust performance of its blockbuster weight loss and diabetes drugs Zepbound and Mounjaro.

Eli Lilly to acquire Morphic via tender offer 08-Jul-2024 ShareCast
Roche sees positive results from weight-loss tri... 16-May-2024 ShareCast
Eli Lilly hikes sales guidance by $2bn, shares j... 30-Apr-2024 ShareCast
Eli Lilly weight-loss drug 'significantly' reduc... 17-Apr-2024 ShareCast
Eli Lilly to buy Point Biopharma in $1.4bn deal 03-Oct-2023 ShareCast
Eli Lilly hikes guidance despite first-quarter e... 27-Apr-2023 ShareCast
Eli Lilly to buy genetic medicine developer Akou... 18-Oct-2022 ShareCast
Eli Lilly misses Q3 estimates, but sales top exp... 26-Oct-2021 ShareCast
Eli Lilly posts slightly weaker than expected Q2... 03-Aug-2021 ShareCast
Eli Lilly buys Protomer Technologies in $1bn deal 14-Jul-2021 ShareCast
Eli Lilly Covid-19 therapy works against new vir... 10-Mar-2021 ShareCast
Eli Lilly therapy shown to reduce death in Covid... 10-Mar-2021 ShareCast
Eli Lilly gets EUA for new antibody 'cocktail', ... 10-Feb-2021 ShareCast
Regeneron Pharmaceuticals Covid-19 antibodies 10... 26-Jan-2021 ShareCast
Eli Lilly treatment cuts Covid-19 risk by 80% in... 22-Jan-2021 ShareCast
Eli Lilly to buy Prevail Therapeutics; lifts 202... 15-Dec-2020 ShareCast
AbCellera looks to net up to $391m from IPO 07-Dec-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 750.26
Change Today $ 2.25
% Change 0.30 %
52 Week High $960.02
52 Week Low $570.21
Volume 1,668,494
Shares Issued 949.78m
Market Cap $712,583m
Beta 0.93
RiskGrade 179

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Nov-2024

Time Volume / Share Price
13:57 100 @ $750.26
13:57 100 @ $750.37
13:57 100 @ $750.34
13:57 100 @ $750.35
13:57 100 @ $750.35

Top of Page